SD-101-6.0 cream ( DrugBank: - )

1 disease

ID	Disease name (Link within this page)	Number of trials
36	Epidermolysis bullosa	2

36. Epidermolysis bullosa

Clinical trials : 163 / Drugs : 185 - (DrugBank : 46) / Drug target genes : 50 - Drug target pathways : 125

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02670330 (ClinicalTrials.gov)	June 9, 2015	28/7/2015	Open Label Extension Study to Evaluate the Long-term Safety of Zorblisa (SD-101-6.0) in Patients Wit ...	An Open Label Multi-Center Extension Study to Evaluate the Long-term Safety of Zorblisa™ (SD-101-6.0 ...	Epidermolysis Bullosa	Drug: SD-101-6.0 cream	Scioderm, Inc.	Amicus Therapeutics	Terminated	1 Month	N/A	All	152	Phase 3	United States;Australia;Austria;France;Germany;Israel;Lithuania;Netherlands;Poland;Serbia;Spain;Unit ...
2	NCT02384460 (ClinicalTrials.gov)	March 11, 2015	13/2/2015	ESSENCE Study: Efficacy and Safety of SD-101 Cream in Participants With Epidermolysis Bullosa	A Phase 3, Multi-center, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safe ...	Epidermolysis Bullosa	Drug: SD-101-6.0 cream;Drug: Placebo (SD-101-0.0) cream	Scioderm, Inc.	Amicus Therapeutics	Completed	1 Month	N/A	All	169	Phase 3	United States;Australia;Austria;France;Germany;Israel;Italy;Lithuania;Netherlands;Poland;Serbia;Spai ...

First Previous1Next Last